Background The evidence that body composition parameters influence multiple cancer
outcomes is rapidly expanding. Excess adiposity deposits in muscle tissue, termed …

Background Myosteatosis has been reported to be a novel biomarker that could predict
survival outcomes in patients with colorectal cancer. However, results have been conflicting …

Myosteatosis, which is excessive fat infiltration in the skeletal muscle, is now considered a
distinct disease from sarcopenia. Advances in imaging technique have made muscle …

Background & aims Patients with pancreatic cancer have a poor prognosis, are often
cachectic, and frequently demonstrate features of systemic inflammation, which may …

There is growing interest from the oncology community to understand how body composition
measures can be used to improve the delivery of clinical care for the 18.1 million individuals …

Advancements in image-based technologies and body composition research over the past
decade has led to increased understanding of the importance of muscle abnormalities, such …

Loss of lean body develops from an imbalance in protein synthesis and catabolism and is
associated with a variety of different disease and nondisease states, including severe …

Computed tomography (CT) and magnetic resonance imaging (MRI) can quantify muscle
mass and quality. However, it is still unclear if CT and MRI derived measurements can be …

Body composition, defined as the proportions and distribution of lean and fat tissues in the
human body, is an emergent theme in clinical oncology. Severe muscle depletion …

Background Computed tomography (CT) analysis of body composition has garnered interest
as a potential prognostic tool in those with cancer. A range of pre‐defined thresholds …